Why the study?
Do different beta-adrenoceptor antagonists have varying effects on heart rate and peak expiratory flow rate during exercise in healthy volunteers?
Do different beta-adrenoceptor antagonists have varying effects on heart rate and peak expiratory flow rate during exercise in healthy volunteers?
Beta-blockers with partial agonist activity (oxprenolol, pindolol) may preserve exercise-induced bronchodilation compared to those without, while providing similar heart rate control.
Answers are grounded in this paper and cite their sources.
ISA beta-blockers preserve exercise PEFR unlike non-ISA agents at matched HR reduction; extends evidence for agent-specific airway effects.
1 The effects of beta-adrenoceptor antagonists given in single doses by oral or intravenous routes were examined in two double-blind controlled studies performed in healthy volunteers. Heart rate and peak expiratory flow rate (PEFR) were measured at rest and during standardized exercise. 2 Propranolol 80 mg and metoprolol 100 mg orally tended to reduce, and propranolol and metoprolol 0.2 mg/kg intravenously did reduce the physiological increase in PEFR during exercise; oxprenolol 80 mg orally and 0.2 mg/kg intravenously did not. Practolol 200 mg orally reduced this increase, but practolol 1 mg/kg intravenously did not. 3 In a third study of similar design, pindolol 0.05 mg/kg intravenously did not affect exercise-induced increase in PEFR. 4 Heart rate during exercise was reduced to a comparable extent at different times by all the active treatments. 5 Oxprenolol and pindolol share with practolol the property of partial agonist activity, which might contribute to their apparent lack of effect on airways resistance. A further possibility is that alpha-adrenoceptor blockade helps to maintain exercise-induced increase in PEFR.
No takes yet. Share an insight, caveat, or question.
Oh et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: